E-LIB Suche - Ergebnisse für: Villain, Nicolas

1

Cognitive impairment in children and adults with cerebroten..:

Salardaine, Quentin ; Shor, Natalia ; Villain, Nicolas...
Journal of Inherited Metabolic Disease. , 2024

Link: https://doi.org/10.1002/..

2

What is Alzheimer's disease? An analysis of nosological per..:

Villain, Nicolas ; Michalon, Robin
European Journal of Neurology. , 2024

Link: https://doi.org/10.1111/..

3

Evaluation of SP3 for antibody-free quantification of tau i..:

Jacquemin, Chloé ; Villain, Nicolas ; Azevedo, Rita...
European Journal of Mass Spectrometry. 30 (2024) 1 - p. 65-75 , 2024

Link: https://doi.org/10.1177/..

4

Posterior cortical atrophy: new insights into treatments an..:

Bejanin, Alexandre ; Villain, Nicolas
The Lancet Neurology. 23 (2024) 2 - p. 127-128 , 2024

Link: https://doi.org/10.1016/..

5

Prognostic and Predictive Factors in Early Alzheimer's Dise..:

Garcia, Maria João ; Leadley, Regina ; Ross, Janine...
Journal of Alzheimer's Disease Reports. 8 (2024) 1 - p. 203-240 , 2024

Link: https://doi.org/10.3233/..

6

BD-tau plasmatique : un biomarqueur spécifique de la gravit..:

Piga, Giuseppe ; Gonzalez-Ortiz, Fernando ; Yuksekel, Idil...
Revue Neurologique. 180 (2024) - p. S165-S166 , 2024

Link: https://doi.org/10.1016/..

7

A Comparison Between Early Presentation of Dementia with Le..:

Nedelec, Thomas ; Couvy‐Duchesne, Baptiste ; Darves‐Bornoz, Aube...
Annals of Neurology. 94 (2023) 2 - p. 259-270 , 2023

Link: https://doi.org/10.1002/..

8

Integrated Mass Spectrometry‐based Pipeline for Characteriz..:

Azevedo, Rita ; Villain, Nicolas ; Boluda, Susana...
Alzheimer's & Dementia. 19 (2023) S2 - p. , 2023

Link: https://doi.org/10.1002/..

9

Dementia prevention in memory clinics: recommendations from..:

Frisoni, Giovanni B. ; Altomare, Daniele ; Ribaldi, Federica...
The Lancet Regional Health - Europe. 26 (2023) - p. 100576 , 2023

Link: https://doi.org/10.1016/..

10

Cerebral amyloid angiopathy frequency at baseline and after..:

Blanc, Clémence ; Houot, Marion ; Villain, Nicolas...
Alzheimer's & Dementia. 19 (2023) S16 - p. , 2023

Link: https://doi.org/10.1002/..

11

Interpreting trial results in an era of disease‐modifying t..:

Raket, Lars Lau ; Cummings, Jeffrey L. ; Moscoso, Alexis..
Alzheimer's & Dementia. 19 (2023) S21 - p. , 2023

Link: https://doi.org/10.1002/..

12

Key questions for the evaluation of anti-amyloid immunother..:

Liu, Kathy Y ; Villain, Nicolas ; Ayton, Scott...
Brain Communications. 5 (2023) 3 - p. , 2023

Link: https://doi.org/10.1093/..

13

Meta‐analysis of high‐clearance anti‐amyloid immunotherapie..:

Villain, Nicolas ; Planche, Vincent
Alzheimer's & Dementia. 19 (2023) S7 - p. , 2023

Link: https://doi.org/10.1002/..

14

Immunothérapies anti-amyloïdes à forte clairance (IAAFC) da..:

Villain, Nicolas ; Planche, Vincent ; Levy, Richard
Revue Neurologique. 179 (2023) - p. S5 , 2023

Link: https://doi.org/10.1016/..

15

Can a failure in the error-monitoring system explain unawar..:

Razafimahatratra, Solofo ; Guieysse, Thomas ; Lejeune, François-Xavier...
Cortex. 166 (2023) - p. 428-440 , 2023

Link: https://doi.org/10.1016/..